1 Result: NYSE:BMY
FDA expands approved use of Opdivo in advanced lung cancer
October 11th, 2015
Redistributed by CRWEPRESSRELEASE Opdivo demonstrates survival benefit in squamous and non-squamous non-small cell lung cancer Release Date: October 9, 2015 The U.S. Food and Drug Administration today approved Opdivo (nivolumab) to treat pat. Read more
Want To Find Some News?
News By Industries
August 30th, 2016August 29th, 2016August 29th, 2016